Table 3

Unadjusted linear regressions investigating the associations between HbA1c and sedentary time*, BMI, age and use of antidiabetic drugs in patients with or without DM

	All patients (n=379)			No DM (n=305)			DM (n=74)
	β	CI	P value	β	CI	P value	β	CI	P value
Total sedentary time	0.18	0.08 to 0.29	<0.001	−0.03	−0.15 to 0.08	0.598	0.38	0.16 to 0.60	0.001
Bout-length category (min)
<30	−0.07	−0.20 to 0.00	0.059	−0.06	−0.18 to 0.05	0.273	−0.08	−0.31 to 0.15	0.510
30–59	0.09	−0.01 to 0.20	0.075	0.03	−0.09 to 0.14	0.616	0.04	−0.20 to 0.27	0.754
60–89	0.14	0.04 to 0.25	0.005	0.06	−0.06 to 0.17	0.326	0.24	−0.02 to 0.44	0.067
≥90	0.07	−0.03 to 0.17	0.007	−0.03	−0.15 to 0.08	0.595	0.32	0.10 to 0.54	0.006
BMI	0.15	0.04 to 0.25	0.002	0.16	0.04 to 0.28	0.009	−0.10	−0.34 to 0.14	0.427
Age	0.08	−0.02 to 0.19	0.110	0.17	0.06 to 0.29	0.003	0.05	−0.18 to 0.29	0.657
Antidiabetic drugs	0.72	0.50 to 0.93	<0.001	–	–	–	0.51	0.10 to 0.93	<0.001

BMI=weight/height².
Antidiabetic drugs are defined as Anatomical Therapeutic Chemical A10.
*Sedentary time is analysed as total time (mean hours/day) and by bout-length category (mean hours/day).
.BMI, body mass index; DM, diabetes mellitus; HbA1c, glycated haemoglobin.